Domain Associates
Eckard Weber is a prominent figure in the biotechnology sector, currently serving as Founder and Chief Innovation Officer at Transposon Therapeutics, Inc. since April 2020, and as Founder and Chief Executive Officer at PrimeFour Therapeutics, Inc. since January 2021. Additionally, Eckard Weber holds the position of Entrepreneur-in-Residence at Canaan Partners and has been an Advisory Partner and Partner at Domain Associates since January 2001, focusing on biotechnology entrepreneurship and venture capital investing. Formerly, Eckard Weber served as CEO of Cytovia, Inc. and held senior research roles at Cocensys, Inc. and various academic positions, including Professor of Pharmacology at UC Irvine. Eckard Weber began a distinguished academic career in neuroscience at institutions such as Oregon Health Sciences University and Stanford University, following a medical degree from the University of Ulm.
This person is not in the org chart
This person is not in any offices
Domain Associates
Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on investing in life science companies that advance human health. Domain’s focused network, deep experience, and dependable reputation of this team have made it one of the top private-equity groups participating in healthcare investing. With $2.4 billion of capital under management, Domain invests in three major segments: pharmaceuticals, diagnostics, and medical devices.